267644-49-5Relevant articles and documents
Probes for imidazoline binding sites: Synthesis and evaluation of a selective, irreversible I2 ligand
Coates, Philippa A.,Grundt, Peter,Robinson, Emma S.J.,Nutt, David J.,Tyacke, Robin,Hudson, Alan L.,Lewis, John W.,Husbands, Stephen M.
, p. 605 - 607 (2000)
An irreversible ligand (7) has been prepared based on the selective I2 ligand 2-BFI. Compound 7 displayed high affinity and selectivity for I2-sites and has been shown to irreversibly bind to these sites in rat brain. Compound 7 should, therefore, prove an invaluable tool for the further elucidation of I2-site function. (C) 2000 Elsevier Science Ltd. All rights reserved.
Pyrimidine heterocyclic compounds, pyrimidine heterocyclic compound salts, and preparation method and application thereof
-
Paragraph 0147; 0154; 0155; 0156, (2017/07/26)
The invention provides pyrimidine heterocyclic compounds, pyrimidine heterocyclic compound salts, and a preparation method and application thereof. According to the pyrimidine heterocyclic compounds provided by the invention, specific Rq is selected, so that the obtained compounds have favorable drug resistance and long half life when being used as the medicine for treating or preventing HIV. The compounds have the advantages of high activity, low toxicity and high stability.
PROCESS FOR THE PREPARATION OF VILAZODONE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
-
Page/Page column 14; 15, (2014/05/07)
The present invention provides a novel intermediate of vilazodone and its process of preparation. The present invention further provides a process for preparing vilazodone or a pharmaceutically acceptable salt thereof using said novel intermediate.